References
- Prichard B NC, Walden R J. The syndrome associated with the withdrawal of beta‐adrenergic receptor blocking drugs. Br Heart J 1972; 34: 1042–44
- Kristensen B Ø, Steiness E, Weeke J. Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin Pharmacol Ther 1978; 23: 624–9
- KØlendorf K, MØller B D, Rogowski P. The influence of chronic renal failure on serum and urinare thyroid hormone levels. Acta Endocrinol 1978; 98: 80–6
- Faber J, Rogowski P, Kirkegaard C, Siersbak‐Nielsen K, Friis T. Serum free T4 T3 3,3′,5′‐tri‐iodothyronine, 3,3′‐diiodothyronine measured by ultrafiltration. Acta Endocrinol 1984; 107: 357–65
- Rangno R E, Langlois S. Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. Br J Clin Pharmacol 1982; 13: 345s–351s
- Walden R J, Bhattacharjee P, Tomlinson B, Cashin J, Graham B R, Prichard B NC. The effect of intrinsic sympathomimetic activity on beta‐receptor responsiveness after beta‐adrenoceptor blockade withdrawal. Br J Clin Pharmacol 1982; 13: 359s–364s
- Ross P J, Lewis M J, Sheridan D J, Henderson A N. Adrenergic hypersensitivity after betablocker withdrawal. Br Heart J 1981; 45: 637–42
- Schwartz J, Jackson G, Kates R E, Harrison D C. A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol. Eur Heart J 1981; 2: 31–9
- Szecsi E, Kohlschlütter S, Schiess W, Lang E. Abrupt withdrawal of pindolol or metoprolol after chronic therapy. Br J Clin Pharmacol 1982; 13: 353s–357s
- O'Brien E T, Mackinnow J. Propranolol and polythiazide in treatment of hypertension. Br Heart J 1972; 34: 1042–44
- Pedersen O L. Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. Eur J Clin Pharmacol 1976; 10: 381–5
- Bolli B, Bühler F R, Raeder E A, Amann F W, Meier M, Rogg H, Burckhardt D. Lack of beta‐adrenoreceptor hypersensitivity after abrupt withdrawal of long‐term therapy with oxprenolol. Circulation 1981; 64: 1130–4
- Boudoulas H, Lewis R P, Kates E, Dalamangos G. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Intern Med 1977; 87: 433–6
- Rangno R E, Langlois S, Lutterodt A. Metoprolol withdrawal phenomena: mechanism and prevention. Clin Pharmacol Ther 1982; 31: 8–15
- Rangno R E, Langlois S, Stewart J. Cardiac hyper‐ and hyporesponsiveness after pindolol withdrawal. Clin Pharmacol Ther 1982; 31: 564–71
- Molinoff P B, Aarons R D, Nies A S, Gerber J G, Wolfe B B, Goens M B. Effect of pindolol and propanolol on beta‐adrenergic receptors on human lymphocytes. Br J Clin Pharmacol 1982; 13: 365s
- Aarons R D, Nies A S, Gal J, Hegstrand L R, Molinoff P B. Elevation of beta‐adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest 1980; 65: 949–57
- Ross P J, Jones M K, John R. Thyroid hormone levels after propranolol withdrawal. Clin Sci 1980; 58: 22
- Rangno R E, Nattel S. Mechanisms of beta‐adrenergic blockade withdrawal phenomena. Beta‐blockade and Anaesthesia, P J Pappers, B van Dijk, A WM van elzakker. Astra Pharmaceutica BV, The Netherlands 1980; 139–49
- Wartofsky L, Burman K D. Alterations in thyroid function in patients with systemic illness: The ‘euthyroid sick syndrome’. Endocr Rev 1982; 3: 164–217